Erratum: SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers

iScience. 2023 Oct 25;26(11):108302. doi: 10.1016/j.isci.2023.108302. eCollection 2023 Nov 17.

Abstract

[This corrects the article DOI: 10.1016/j.isci.2023.106027.].

Publication types

  • Published Erratum